Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation
Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng
Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng
View: Text | PDF
Research Article Angiogenesis Vascular biology

Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation

  • Text
  • PDF
Abstract

Loss-of-function mutations in cerebral cavernous malformation (CCM) genes and gain-of-function mutation in the MAP3K3 gene encoding MEKK3 cause CCM. Deficiency of CCM proteins leads to the activation of MEKK3-KLF2/4 signaling, but it is not clear how this occurs. Here, we demonstrate that deletion of the CCM3 interacting kinases STK24/25 in endothelial cells causes defects in vascular patterning during development as well as CCM lesion formation during postnatal life. While permanent deletion of STK24/25 in endothelial cells caused developmental defects of the vascular system, inducible postnatal deletion of STK24/25 impaired angiogenesis in the retina and brain. More importantly, deletion of STK24/25 in neonatal mice led to the development of severe CCM lesions. At the molecular level, a hybrid protein consisting of the STK kinase domain and the MEKK3 interacting domain of CCM2 rescued the vascular phenotype caused by the loss of ccm gene function in zebrafish. Our study suggests that CCM2/3 proteins act as adapters to allow recruitment of STK24/25 to limit the constitutive MEKK3 activity, thus contributing to vessel stability. Loss of STK24/25 causes MEKK3 activation, leading to CCM lesion formation.

Authors

Xi Yang, Shi-Ting Wu, Rui Gao, Rui Wang, Yixuan Wang, Zhenkun Dong, Lu Wang, Chunxiao Qi, Xiaohong Wang, M. Lienhard Schmitz, Renjing Liu, Zhiming Han, Lu Wang, Xiangjian Zheng

×

Figure 4

Limited induction time window of CCM formation in the Stk24- and Stk25-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Limited induction time window of CCM formation in the Stk24- and Stk25-d...
(A) Schematic of 4-HT injection and sample collection. Pups were intragastrically injected with 4-HT at P5, and the brain tissues were harvested at P12 and P21. The survival curves of Stk24/25idECKO (n = 14) and Stk24fl/fl;Stk25fl/fl mice (n = 16) after 4-HT induction at P5 are shown below. Statistical analysis was performed using the Mantel-Cox test. ****P < 0.0001. (B) Stereomicroscopic images and μCT images of CCM lesions in Stk24/25idECKO mice at P12 and P21 with 4-HT induction at P5. Scale bars: 2 mm. Quantitative analysis of lesion volume in cerebrum (n = 3) and cerebellum (n = 3) at P12 and P21 is shown on the right. Data are presented as mean ± SD. (C) Stereomicroscopic images and μCT imaging of CCM lesions in Stk24/25idECKO (n = 3) mice after tamoxifen induction at P7. Scale bars: 2 mm. (D) H&E staining of brain sections and whole-mount images showing CCM in brain and retina of Stk24fl/fl;Stk25fl/fl (n = 3) and Stk24/25idECKO mice (n = 3) at different time points. Scale bars: 200 μm. (E) Stereomicroscopic images and μCT images showing diminished CCM lesion formation in the Stk24/25idECKO mice (n = 3) at P30 after tamoxifen induction starting at P10. Scale bars: 2 mm. (F) Stereomicroscopic images and μCT imaging showing near absence of CCM lesion formation in the Stk24/25idECKO mice (n = 3) at P29 after tamoxifen induction starting at P15. Scale bars: 2 mm. Representative images from 3 or more independent experiments are shown.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts